umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Decrease in adiponectin levels correlates to growth response in growth hormone-treated children
Department of Pediatrics, Göteborg Pediatric Growth Research Center, The Institute of Clinical Sciences. (The Swedish Study Group for Growth Hormone Treatment)
Institute of Medicine, The Sahlgrenska Academy at Göteborg University, Göteborg, Sweden. (The Swedish Study Group for Growth Hormone Treatment)
Institute of Medicine, The Sahlgrenska Academy at Göteborg University, Göteborg, Sweden. (The Swedish Study Group for Growth Hormone Treatment)
Department of Pediatrics, Göteborg Pediatric Growth Research Center, The Institute of Clinical Sciences. (The Swedish Study Group for Growth Hormone Treatment)
Show others and affiliations
2009 (English)In: Hormone Research, ISSN 0301-0163, E-ISSN 1423-0046, Vol. 71, no 4, 213-218 p.Article in journal (Refereed) Published
Abstract [en]

BACKGROUND/AIMS: Adiponectin is secreted by adipose tissue and circulates in human plasma at high levels. Decreased adiponectin levels are associated with insulin resistance and obesity. The aim of this study was to investigate whether changes in serum adiponectin levels are related to the growth response, insulin levels and insulin resistance during growth hormone (GH) treatment. METHODS: The study included 94 short prepubertal children (19 girls and 75 boys). The mean age at the start of daily GH injections was 9.04 +/- 2.38 years. Adiponectin levels in serum were measured using an ELISA. RESULTS: At baseline, adiponectin correlated with the first-year growth response (r = 0.26, p = 0.012). Adiponectin decreased significantly after 1 week, 3 months and 1 year from 14.5 +/- 5.71 to 13.1 +/- 5.22 (p < 0.0001), 10.3 +/- 4.82 (p < 0.0001) and 12.5 +/- 5.34 microg/ml (p < 0.0001), respectively. There were significant correlations between the first-year growth response and the decrease in adiponectin levels after 3 months and 1 year (r = -0.38, p < 0.0001 and r = -0.47, p < 0.0001, respectively). No correlations between adiponectin, insulin and the homeostasis model assessment of insulin resistance were seen. CONCLUSIONS: GH treatment in prepubertal children decreases serum adiponectin levels, and the decrease is correlated to the growth response. No correlations between adiponectin and insulin levels or insulin resistance were found.

Place, publisher, year, edition, pages
2009. Vol. 71, no 4, 213-218 p.
Keyword [en]
Adiponectin, Children, Growth hormone, Insulin-like growth factor-I, Insulin, Growth response
National Category
Pediatrics
Identifiers
URN: urn:nbn:se:umu:diva-35020DOI: 10.1159/000201110PubMedID: 19258713OAI: oai:DiVA.org:umu-35020DiVA: diva2:328310
Available from: 2010-07-02 Created: 2010-07-02 Last updated: 2017-12-12Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed
In the same journal
Hormone Research
Pediatrics

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 47 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf